Investors:
3B Future Health Fund
3i Group plc
Accequa
AdBio Partners
AltamarCAM Partners
Alternative Assets Finance
AMR Action Fund GP GmbH
ARCHIMED
Argobio Studio
Bergaud & Partners
BERNINA BioInvest Ltd.
BioMedPartners AG
BIOSTART Consulting GmbH
BlackRock
Blackstone Group
Bpifrance
Breslin AG
Brightlands Venture Partners
Capital Grand Est
Claris Ventures
Convergence Partners
DeBere Partners Limited
European Braintech Fund
European Investment Bank
European Investment Fund
FastVentures B.V.
Forty51 Ventures AG
Fresenius Ventures
Generation Fund Life Sciences Fund I
Gilde Healthcare Partners BV
Gimv
Goetzpartners Securities
GOLDTRACK Ventures GmbH
High-Tech Gründerfonds Management GmbH
i&i Biotech Fund I SCSp
ICF Consult Switzerland
INOGROUP GmbH
Invariant Capital AG
IPF Partners
Italian Angels for Growth (IAG)
Kaleida Capital Management LLC
Karista
Kinled Holding Limited
Lifespan Vision Ventures LLC
Lynx Financial Hong Kong Ltd.
Mérieux Equity Partners
Mission BioCapital
MTIP AG
NxR Biotechnologies GmbH
Oncode Accelerator
Oxford Science Enterprises plc
Panakès Partners SGR SpA
Peppermint VenturePartners GmbH
Peregrine Ventures
Rahim Invest SÀRL
RV Invest GmbH
Seventure Partners
Ship2B Ventures
Stifel
Sunstone Life Science Ventures
TheraVenture GmbH
TVM Capital Life Science
UCB Ventures
UZH Life Sciences Fund, AG
Verge HealthTech Fund
Versant Ventures
Vi Partners AG
Viopas Venture Consulting GmbH
Wellington Partners
WG Partners LLP
XGEN Venture SGR S.p.A.
YAYA Capital
Zühlke Ventures AG
Last updated: September 4, 2026